EDGAR Filing Documents for 0001193125-12-227792

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001193125-12-227792

Filing Date

2012-05-11

Accepted

2012-05-11 13:27:34

Documents

Period of Report

2012-03-31

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 10-Q	d331647d10q.htm	10-Q	331468
2	CERTIFICATION PURSUANT TO RULE 13A-14(A)	d331647dex311.htm	EX-31.1	10695
3	CERTIFICATION PURSUANT TO RULE 13A-14(A)	d331647dex312.htm	EX-31.2	10699
4	CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350	d331647dex321.htm	EX-32.1	5452
5	CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350	d331647dex322.htm	EX-32.2	5456
	Complete submission text file	0001193125-12-227792.txt		1778431

Data Files

Seq	Description	Document	Type	Size
6	XBRL INSTANCE DOCUMENT	galt-20120331.xml	EX-101.INS	166773
7	XBRL TAXONOMY EXTENSION SCHEMA	galt-20120331.xsd	EX-101.SCH	17348
8	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE	galt-20120331_cal.xml	EX-101.CAL	29316
9	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE	galt-20120331_def.xml	EX-101.DEF	101592
10	XBRL TAXONOMY EXTENSION LABEL LINKBASE	galt-20120331_lab.xml	EX-101.LAB	137717
11	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	galt-20120331_pre.xml	EX-101.PRE	120463

Mailing Address 7 WELLS AVENUE STE 34 NEWTON MA 02459

Business Address 7 WELLS AVENUE STE 34 NEWTON MA 02459 617-559-0033

GALECTIN THERAPEUTICS INC (Filer) CIK: 0001133416 (see all company filings)